Status:
NOT_YET_RECRUITING
Effect of Levonorgestrel Intrauterine System on Hemoglobin Level
Lead Sponsor:
Assiut University
Conditions:
Hemoglobin; Deficiency
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
To study the effect of LNG-IUS on improving iron status in reproductive-aged women presenting for contraception.
Detailed Description
Women come to family planning clinic to insert levonorgestrel intrautrine system and take a blood sample from her to analyse hemoglobin level
Eligibility Criteria
Inclusion
- The study will include married women attending the outpatient clinics of the forementioned health facilities for contraception counseling
- Age between 18 and 45 years
- Women who choose LNG\_IUS for contraception
- Any parity including nulliparous
Exclusion
- Women with any inherited hemoglobinopathy (thalassemia, sickle cell anemia) or acquired hemolytic anemia 2.Women with sever iron deficiency anemia requiring immediate treatment 3.Women with any contraindication to Mirena insertion (pelvic inflammatory disease, cervical or vaginal infection, cervical cancer) 4. Any uterine abnormality making LNG\_IUS insertion difficult (septate uterus or fibroid distorting the cavity) 5. Women within 6 months of delivery
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06935968
Start Date
May 1 2025
End Date
July 1 2026
Last Update
April 20 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.